These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8567880)

  • 21. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
    Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
    Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
    Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors.
    Paula SB; Morey AT; Santos JP; Santos PM; Gameiro DG; Kerbauy G; Sena EM; Ueda LT; Carneiro M; Pinge-Filho P; Yamauchi LM; Yamada-Ogatta SF
    J Infect Dev Ctries; 2015 Dec; 9(12):1350-9. PubMed ID: 26719941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro study of oral Candida albicans in virulence from HIV-positive individuals].
    Liu XS; Liu HW; Guo ZJ; Luan WM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 May; 40(3):211-4. PubMed ID: 15938881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode.
    Vargas K; Messer SA; Pfaller M; Lockhart SR; Stapleton JT; Hellstein J; Soll DR
    J Clin Microbiol; 2000 Oct; 38(10):3595-607. PubMed ID: 11015370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
    White A; Goetz MB
    Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
    Ruhnke M; Schmidt-Westhausen A; Trautmann M
    Antimicrob Agents Chemother; 1997 Mar; 41(3):575-7. PubMed ID: 9055995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.
    Lasker BA; Elie CM; Lott TJ; Espinel-Ingroff A; Gallagher L; Kuykendall RJ; Kellum ME; Pruitt WR; Warnock DW; Rimland D; McNeil MM; Reiss E
    Med Mycol; 2001 Aug; 39(4):341-52. PubMed ID: 11556764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.
    Lin JN; Lin CC; Lai CH; Yang YL; Chen HT; Weng HC; Hsieh LY; Kuo YC; Lauderdale TL; Tseng FC; Lin HH; Lo HJ
    J Microbiol Immunol Infect; 2013 Apr; 46(2):129-35. PubMed ID: 22921200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5.
    Nikawa H; Jin C; Makihira S; Hamada T; Samaranayake LP
    J Prosthet Dent; 2002 Sep; 88(3):263-7. PubMed ID: 12426495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
    Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.